Ingredient

Ertugliflozin L-Pyroglutamic Acid

Ertugliflozin L-Pyroglutamic acid is a blood glucose-lowering ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
4
Single ingredient
2
Combination
2
Prescription medication
4

MFDS ingredient code M268102

What does it do?

Ertugliflozin L-Pyroglutamic acid belongs to the class of SGLT2 inhibitors and is used as an antidiabetic ingredient. This ingredient is used to block glucose reabsorption in the kidneys to help control blood sugar.

This ingredient inhibits the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, which increases the excretion of glucose in the urine. As a result, blood glucose levels decrease, aiding in blood sugar control.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Ertugliflozin L-Pyroglutamic acid is similar to other SGLT2 inhibitors, but it is characterized by its combined form with L-Pyroglutamic acid, which improves stability and absorption rate. This leads to effective blood glucose-lowering effects.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

4 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.